GS, M., RJ, H., J, I., S, E., & SM, E. (2019). Transition from Hemochron Response to Hemochron Signature Elite Activated Clotting Time Devices in a Congenital Cardiac Surgery Practice. The journal of extra-corporeal technology, 51(4), 221. https://doi.org/10.1182/ject-1900024
Chicago Style (17th ed.) CitationGS, Matte, Howe RJ, Ibla J, Emani S, and Emani SM. "Transition from Hemochron Response to Hemochron Signature Elite Activated Clotting Time Devices in a Congenital Cardiac Surgery Practice." The Journal of Extra-corporeal Technology 51, no. 4 (2019): 221. https://doi.org/10.1182/ject-1900024.
MLA (9th ed.) CitationGS, Matte, et al. "Transition from Hemochron Response to Hemochron Signature Elite Activated Clotting Time Devices in a Congenital Cardiac Surgery Practice." The Journal of Extra-corporeal Technology, vol. 51, no. 4, 2019, p. 221, https://doi.org/10.1182/ject-1900024.